Present status of biological response modifiers in cancer.
Parkinson
D R
DR
National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20852, USA.
D002986:Clinical Trials as Topic; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007378:Interleukins / Q000627:therapeutic use; D009369:Neoplasms / Q000098:blood supply / Q000276:immunology / Q000628:therapy*; D009389:Neovascularization, Pathologic / Q000628:therapy; D014614:Vaccines, Synthetic
D007155:Immunologic Factors; D007378:Interleukins; D014614:Vaccines, Synthetic